Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes
Toshio Nishikimi(Kyoto University), Kenji Kangawa(National Cerebral and Cardiovascular Center), Fumiki Yoshihara(National Cerebral and Cardiovascular Center), Hisayuki Matsuo(National Cerebral and Cardiovascular Center), Takeshi Horio, Noritoshi Nagaya(National Cerebral and Cardiovascular Center)
Cited by 71
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Increased plasma levels of adrenomedullin in patients with heart failure
|Journal of the American College of Cardiology|1995|307